Drimva

AstraZeneca

Senior Director, Delivery Cell Therapy

$170K–$256K

US - Gaithersburg - MD · Director · Full-time · Posted Oct 30, 2026

Experience
12+ years of relevant experience, including 5+ years of leadership experience.
Education
Advanced degree, such as an MSc, MBA or equivalent, in supply chain, life sciences, engineering, business or a related discipline.

About the job

Leads AstraZeneca’s global Cell Therapy Delivery team to manage supplier risk and relationships, secure direct materials, and build resilient supply networks from clinical development through commercial delivery.

What you'll do

  • Develop and lead supplier risk and Supplier Relationship Management frameworks, including supplier assessments, governance, performance monitoring and continuity planning.
  • Lead critical supplier partnerships and direct-materials supply assurance, addressing escalations, delivery performance, dual sourcing and supplier readiness for scale.
  • Build and develop a global team, embedding analytics, digital capabilities and AI in supplier risk and performance management.

What they ask for

  • 12+ years of relevant supply chain, sourcing, supplier management or risk management experience in pharmaceutical, biotechnology or life sciences environments, including 5+ years of leadership experience.
  • Advanced degree, such as an MSc, MBA or equivalent, in supply chain, life sciences, engineering, business or a related discipline.
  • Experience designing and leading supplier risk management and SRM frameworks in a regulated life sciences environment.
  • Significant direct-materials, supply-assurance or supply-chain leadership experience in pharmaceutical, biotechnology or ATMP environments.

Nice to have

  • Direct experience with CAR-T, autologous, allogeneic or in-vivo cell therapy, or other ATMP supply chains.
  • Experience with CDMOs and complex cell and gene therapy supplier ecosystems.

Pay

$170,456.80 - $255,685.20 USD base salary

Tools

SAP, Coupa

AI focus

Embed analytics and AI into supplier risk monitoring, performance management and expediting.

Model-written summary · the original posting is authoritative

First seen Oct 31, 2026 · Last verified Nov 5, 2026 (UTC)